Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 22 | 9 | 11 | 76 | 68 |
| Gross Profit | 22 | 9 | 11 | 76 | 68 |
| Operating Expenses | 1,720 | 1,409 | 1,739 | 1,518 | 1,540 |
| Operating Income | -1,697 | -1,400 | -1,728 | -1,442 | -1,472 |
| Interest Expense | 0 | 0 | 0 | 3 | 0 |
| Other Income | 17 | 3 | -17 | 6 | 11 |
| Pre-tax Income | -1,680 | -1,397 | -1,745 | -1,439 | -1,462 |
| Net Income Continuous | -1,680 | -1,397 | -1,745 | -1,439 | -1,462 |
| Net Income Discontinuous | N/A | N/A | 1,923 | -136 | 71 |
| Net Income | $-1,680 | $-1,397 | $178 | $-1,575 | $-1,391 |
| EPS Basic Total Ops | -29.29 | -5.76 | 0.68 | -5.28 | -7.68 |
| EPS Basic Continuous Ops | -6.24 | -5.76 | -5.76 | -4.80 | -7.68 |
| EPS Basic Discontinuous Ops | N/A | N/A | 5.76 | -0.88 | 0.34 |
| EPS Diluted Total Ops | -29.29 | -5.76 | 0.68 | -5.28 | -7.68 |
| EPS Diluted Continuous Ops | -6.24 | -5.76 | -5.76 | -4.80 | -7.68 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 5.76 | -0.88 | 0.34 |
| EBITDA(a) | $-1,552 | $-1,258 | $-1,585 | $-1,297 | $-1,308 |